Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4845772 | 1.00 | L3MBTL1 (0.50) | L3MBTL1MEN1KMT2AATMCACNA1H | |
| SCHEMBL23878361 | 0.86 | L3MBTL1 (0.50) | L3MBTL1MEN1KMT2AATMCACNA1H | |
| SCHEMBL22039448 | 0.86 | L3MBTL1 (0.50) | L3MBTL1MEN1KMT2AATMCACNA1H | |
| SCHEMBL4145312 | 0.80 | L3MBTL1 (0.47) | L3MBTL1ACHECYP2C9CYP2C19CYP3A4 | |
| SCHEMBL7194164 | 0.78 | HCRTR1 (0.46) | L3MBTL1CHRM2CHRM1 | |
| SCHEMBL4149720 | 0.78 | HCRTR1 (0.46) | L3MBTL1CHRM2CHRM1 | |
| SCHEMBL29779329 | 0.69 | RORC (0.46) | L3MBTL1RORCCYP2C9CYP2C19CYP3A4 | |
| SCHEMBL29779454 | 0.69 | RORC (0.46) | L3MBTL1RORCCYP2C9CYP2C19CYP3A4 | |
| SCHEMBL27528621 | 0.69 | RORC (0.46) | L3MBTL1RORCCYP2C9CYP2C19CYP3A4 | |
| SCHEMBL5837860 | 0.69 | L3MBTL1 (0.58) | L3MBTL1MEN1KMT2ACHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090012144-A1 | Optically active 2,5-bisaryl-delta¹ -pyrrolines and their use as pest control agents | PLANT ANDREW | 2009-01-08 | — | — | US | disclosed |
| US-7419936-B2 | Optically active 2,5-bisaryl-Δ1-pyrrolines and their use as pest control agents | BAYER CROPSCIENCE AG (DE) | 2008-09-02 | — | — | US | disclosed |
| CN-1630634-A | Optically active 2,5-bisaryl-delta1-pyrrolines and their use as pest control agents | BAYER CROPSCIENCE AG (DE) | 2005-06-22 | — | — | CN | disclosed |
| EP-1322607-A1 | OPTICALLY ACTIVE 2,5-BISARYL-DELTA1-PYRROLINES AND THEIR USE AS PEST CONTROL AGENTS | Bayer CropScience AG (DE) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002024643-A1 | OPTICALLY ACTIVE 2,5-BISARYL-DELTA1-PYRROLINES AND THEIR USE AS PEST CONTROL AGENTS | BAYER CROPSCIENCE AG (DE) | 2002-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090012144-A1 | Optically active 2,5-bisaryl-delta¹ -pyrrolines and their use as pest control agents | PLD1, RPS3A, AMY1A | L3MBTL1 291/4885MEN1 2581/4885KMT2A 3981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.